Ophthalmologic Findings and Long-Term Course in Patients With Neurofibromatosis Type 2

American Journal of Ophthalmology

Volumn 141, Issue 6, 2006, Pages

  Bosch, Martina M ^a   Boltshauser, Eugen ^b   Harpes, Paul ^c   Landau, Klara ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CATARACT; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EPIRETINAL MEMBRANE; EVALUATION; EYE DISEASE; FEMALE; HAMARTOMA; HUMAN; LIMB WEAKNESS; MALE; MENINGIOMA; MOTOR NEURON DISEASE; NEUROFIBROMATOSIS; NEUROOPHTHALMOLOGY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VESTIBULOCOCHLEAR NERVE DISEASE; VISION; VISUAL ACUITY;

EID: 33744822484     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.12.042     Document Type: Article

References (57)

1. Parry D.M., Eldridge R., Kaiser-Kupfer M.I., Bouzas E.A., Pikus A., and Patronas N. Neurofibromatosis 2 (NF2). clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52 (1994) 450-461
2. Evans D.G., Huson S.M., Donnai D., et al. A clinical study of type 2 neurofibromatosis. Q J Med 84 (1992) 603-618
3. Evans D.G., Huson S.M., Donnai D., et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29 (1992) 841-846
4. Gardner W., and Frazier C. Bilateral acoustic neurofibromatosis. a clinical study and field survey of a family of five generations with bilateral deafness in thirty-eight members. Arch Neurol Psychiatry 23 (1930) 266-302
5. Kanter W.R., Eldridge R., Fabricant R., Allen J.C., and Koerber T. Central neurofibromatosis with bilateral acoustic neuroma. genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 30 (1980) 851-859
6. Trofatter J.A., MacCollin M.M., Rutter J.L., et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72 (1993) 791-800
7. Rouleau G.A., Merel P., Lutchman M., et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363 (1993) 515-521
8. Kaiser-Kupfer M.I., Freidlin V., Datiles M.B., et al. The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol 107 (1989) 541-544
9. Bouzas E.A., Freidlin V., Parry D.M., Eldridge R., and Kaiser-Kupfer M.I. Lens opacities in neurofibromatosis 2. further significant correlations. Br J Ophthalmol 77 (1993) 354-357
10. Kaye L.D., Rothner A.D., Beauchamp G.R., Meyers S.M., and Estes M.L. Ocular findings associated with neurofibromatosis type II. Ophthalmology 99 (1992) 1424-1429
11. Landau K., Dossetor F.M., Hoyt W.F., and Muci-Mendoza R. Retinal hamartoma in neurofibromatosis 2. Arch Ophthalmol 108 (1990) 328-329
12. Good W.V., Brodsky M.C., Edwards M.S., and Hoyt W.F. Bilateral retinal hamartomas in neurofibromatosis type 2. Br J Ophthalmol 75 (1991) 190
13. Landau K., and Yasargil G.M. Ocular fundus in neurofibromatosis type 2. Br J Ophthalmol 77 (1993) 646-649
14. Ragge N.K., Baser M.E., Riccardi V.M., and Falk R.E. The ocular presentation of neurofibromatosis 2. Eye 11 pt 1 (1997) 12-18
15. Dossetor F.M., Landau K., and Hoyt W.F. Optic disk glioma in neurofibromatosis type 2. Am J Ophthalmol 108 (1989) 602-603
16. Bosch M.M., Wichmann W., Boltshauser E., and Landau K. Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol (2006)
17. Baser M.E., Friedman J.M., Wallace A.J., Ramsden R.T., Joe H., and Evans D.G. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59 (2002) 1759-1765
18. Sivalingam A., Augsburger J., Perilongo G., Zimmerman R., and Barabas G. Combined hamartoma of the retina and retinal pigment epithelium in a patient with neurofibromatosis type 2. J Pediatr Ophthalmol Strabismus 28 (1991) 320-322
19. Bouzas E.A., Parry D.M., Eldridge R., and Kaiser-Kupfer M.I. Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2. Retina 12 (1992) 103-107
20. Ragge N.K., Baser M.E., Klein J., et al. Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 120 (1995) 634-641
21. Meyers S.M., Gutman F.A., Kaye L.D., and Rothner A.D. Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc 93 (1995) 245-252
22. Wishart J. Case of tumors in the skull, dura mater, and brain. Edinburgh Med Surg J (1822) 393-397
23. Cunliffe I.A., Moffat D.A., Hardy D.G., and Moore A.T. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2. Br J Ophthalmol 76 (1992) 310-312
24. Ragge N.K. Clinical and genetic patterns of neurofibromatosis 1 and 2. Br J Ophthalmol 77 (1993) 662-672
25. Mautner V.F., Tatagiba M., Guthoff R., Samii M., and Pulst S.M. Neurofibromatosis 2 in the pediatric age group. Neurosurgery 33 (1993) 92-96
26. Tonsgard J.H., and Oesterle C.S. The ophthalmologic presentation of NF-2 in childhood. J Pediatr Ophthalmol Strabismus 30 (1993) 327-330
27. Bouzas E.A., Parry D.M., Eldridge R., and Kaiser-Kupfer M.I. Visual impairment in patients with neurofibromatosis 2. Neurology 43 (1993) 622-623
28. Rettele G.A., Brodsky M.C., Merin L.M., Teo C., and Glasier C.M. Blindness, deafness, quadriparesis, and a retinal malformation. the ravages of neurofibromatosis 2. Surv Ophthalmol 41 (1996) 135-141
29. Mautner V.F., Hazim W., Pohlmann K., Berger R., Kluwe L., and Haase W. Ophthalmologic spectrum of neurofibromatosis type 2 in childhood. Klin Monatsbl Augenheilkd 208 (1996) 58-62
30. MacCollin M., and Mautner V.F. The diagnosis and management of neurofibromatosis 2 in childhood. Semin Pediatr Neurol 5 (1998) 243-252
31. Harada T., Sawamura Y., Ohashi T., et al. Severe optic disc edema without hydrocephalus in neurofibromatosis 2. Jpn J Ophthalmol 42 (1998) 381-384
32. Yu C.B., Lyons C.J., Dorrell E.D., and Taylor D. Congenital cavernous sinus syndrome in a child with neurofibromatosis type 2. Can J Ophthalmol 34 (1999) 101-103
33. Bursztyn J., and Rodriguez D. Importance of multidisciplinary consultations for children with neurofibromatosis. J Fr Ophthalmol 22 (1999) 959-962
34. Brodsky M.C., Landau K., Wilson R.S., and Boltshauser E. Morning glory disc anomaly in neurofibromatosis type 2. Arch Ophthalmol 117 (1999) 839-841
35. Tong J.T., and Bateman J.B. Selective B-wave reduction with congenital cataract in neurofibromatosis-2. Ophthalmology 106 (1999) 1681-1683
36. Thomas D.A., Trobe J.D., and Cornblath W.T. Visual loss secondary to increased intracranial pressure in neurofibromatosis type 2. Arch Ophthalmol 117 (1999) 1650-1653
37. Lueder G.T., and Doll J.T. Pseudopapilledema in neurofibromatosis type 2. Am J Ophthalmol 129 (2000) 405-407
38. Onder F., Cosar C.B., Akbatur H., and Kural G. Bilateral retinal involvement as a presenting sign of neurofibromatosis 2. J Pediatr Ophthalmol Strabismus 39 (2002) 49-51
39. Shields J.A., Shields C.L., and Lavrich J. Melanocytoma of optic disk in a patient with neurofibromatosis 2. Retina 22 (2002) 222-223
40. Bosch M.M., Mironov A., and Killer H.E. Atypical manifestation of neurofibromatosis type 2 in a boy. Eye 19 (2005) 705-706
41. Kim J.E., and Ruttum M.S. Neurofibromatosis type 2 in an infant presenting with visual impairment confirmed by genetic mutation analysis. Retina 25 (2005) 938-940
42. Evans D.G., Birch J.M., and Ramsden R.T. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 81 (1999) 496-499
43. Pearson-Webb M.A., Kaiser-Kupfer M.I., and Eldridge R. Eye findings in bilateral acoustic (central) neurofibromatosis. association with presenile lens opacities and cataracts but absence of Lisch nodules. N Engl J Med 315 (1986) 1553-1554
44. Mautner V.F., Lindenau M., Baser M.E., et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38 (1996) 880-885
45. Gass J. Macular dysfunction caused by epiretinal membrane contraction. Stereoscopic atlas of macular diseases. diagnosis and treatment (1987), CV Mosby, St Louis 694-712
46. Wiestler O.D., von Siebenthal K., Schmitt H.P., Feiden W., and Kleihues P. Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2). Acta Neuropathol (Berl) 79 (1989) 137-143
47. Janse A.J., Tan W.F., Majoie C.B., and Bijlsma E.K. Neurofibromatosis type 2 diagnosed in the absence of vestibular schwannomas. a case report and guidelines for a screening protocol for children at risk. Eur J Pediatr 160 (2001) 439-443
48. Perry A., Giannini C., Raghavan R., et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas. a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol 60 (2001) 994-1003
49. Baser M.E., Kuramoto L., Joe H., et al. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2. a population-based study. Am J Hum Genet 75 (2004) 231-239
50. Kluwe L., Mautner V., Heinrich B., et al. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40 (2003) 109-114
51. Nunes F., and MacCollin M. Neurofibromatosis 2 in the pediatric population. J Child Neurol 18 (2003) 718-724
52. Jacoby L.B., Jones D., Davis K., et al. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61 (1997) 1293-1302
53. Kluwe L., and Mautner V.F. Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7 (1998) 2051-2055
54. Klein B.E., Klein R., and Linton K.L. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology 99 (1992) 546-552
55. Egan R.A., and Lessell S. A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophthalmol 120 (2002) 1505-1508
56. Landert M., Baumert B.G., Bosch M.M., Lutolf U.M., and Landau K. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J Neuroophthalmol 25 (2005) 86-91
57. Baser M.E., Friedman J.M., Aeschliman D., et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 71 (2002) 715-723